Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes-Reference-Cited by-同舟云学术

Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes

Published:2008-10 Issue:5 Volume:10 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Habibi Golareh,Leung Samuel,Law Jennifer H,Gelmon Karen,Masoudi Hamid,Turbin Dmitry,Pollak Michael,Nielsen Torsten O,Huntsman David,Dunn Sandra E

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/bcr2156.pdf

Reference32 articles.

1. Sawyers C: The cancer biomarker problem. Nature. 2008, 452: 548-552. 10.1038/nature06913.

2. Harris L, Fritsche H, Mennel R, Norton L, Ravdin P, Taube S, Somerfield MR, Hayes DF, Bast RCJ: American Society for Clinical Oncology 2007: update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol. 2007, 25: 5287-5312. 10.1200/JCO.2007.14.2364.

3. Viale G, Regan MM, Mastropasqua MG, maffinin F, Maiorano E, Colleoni M, Price KN, Golouh R, Perin T, Brown RW, Kovacs A, Pillay K, Ohsschlegel C, Gusterston BA, Castiglione-Gertsch M, Gelber RD, Goldhirsch A, Coates AS: Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer. J Natl Cancer Inst. 2008, 100: 207-212. 10.1093/jnci/djm289.

4. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL: Human breast cancer: correlation of relapse and survival with amplification of HER-2/neu oncogene. Science. 1987, 235: 177-182. 10.1126/science.3798106.

5. Cheang MCU, Treaba DO, Speers CH, Olivotto IA, Bajdik CD, Chia SK, Goldstein LC, Gelmon KA, Huntsman DG, Gilks CB, Nielsen TO, Gown AM: Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal 1D5 in predicting survival. J Clin Oncol. 2006, 24: 5637-5644. 10.1200/JCO.2005.05.4155.

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. YB-1 Targeted by miR-509-3-5p Affects Migration and Invasion of Triple‑Negative Breast Cancer by Regulating Cellular Epithelial‑Mesenchymal Transition;Molecular Biotechnology;2024-03-04

2. Exploration of YBX1 role in the prognostic value and immune characteristics by single‐cell and bulk sequencing analysis for liver hepatocellular carcinoma;The Journal of Gene Medicine;2024-03

3. Size-exclusion chromatography combined with DIA-MS enables deep proteome profiling of extracellular vesicles from melanoma plasma and serum;Cellular and Molecular Life Sciences;2024-02-14

4. Biomechanical and biochemical assessment of YB-1 expression in A375 melanoma cell line: Exploratory study;Frontiers in Molecular Medicine;2023-04-20

5. The WAVE3/β-catenin oncogenic signaling regulates chemoresistance in triple negative breast cancer;Breast Cancer Research;2023-03-22